Sugi Predict

Sugi Predict / Compounds / SCHEMBL15480436

SCHEMBL15480436

SCHEMBL15480436

O=C(CCCCCCC(=O)Nc1c(F)cc(F)cc1F)Nc1c(F)cc(F)cc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 9/20 0.49
▸ HDAC1 Q13547 9/20 0.49
▸ HDAC2 Q92769 6/20 0.49
▸ HDAC6 Q9UBN7 6/20 0.49
▸ FUCA1 P04066 1/20 0.46
▸ HDAC4 P56524 4/20 0.43
▸ HDAC7 Q8WUI4 4/20 0.43
▸ HDAC11 Q96DB2 4/20 0.43
▸ HDAC8 Q9BY41 4/20 0.43
▸ HDAC9 Q9UKV0 4/20 0.43
▸ HDAC5 Q9UQL6 4/20 0.43
▸ HDAC10 Q969S8 3/20 0.43
▸ NCOR2 Q9Y618 1/20 0.43
▸ TSHR P16473 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.40
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15480421 0.93 HDAC1 (0.59) HDAC3HDAC1HDAC2HDAC6HDAC4
SCHEMBL6274678 0.92 HDAC3 (0.43) HDAC3HDAC1HDAC2HDAC6FUCA1
SCHEMBL13973099 0.91 FUCA1 (0.43) HDAC3HDAC1HDAC2HDAC6FUCA1
SCHEMBL15480432 0.81 HDAC1 (0.53) HDAC3HDAC1HDAC2HDAC6HDAC4
SCHEMBL31203323 0.81 HDAC8 (0.60) HDAC3HDAC1HDAC6HDAC8NCOR2
SCHEMBL31203558 0.80 TDP1 (0.49) HDAC3HDAC1HDAC2HDAC6HDAC4
SCHEMBL10114998 0.79 HDAC3 (0.43) HDAC3HDAC1HDAC6FUCA1NCOR2
SCHEMBL10115376 0.79 GRIA1 (0.45) HDAC3HDAC1HDAC6FUCA1SMN1; SMN2
SCHEMBL8536281 0.78 CNR1 (0.52) MAPK1MEN1KMT2AALDH1A1
SCHEMBL8536284 0.78 CNR1 (0.52) MAPK1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210060014-A1 COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS CERENO SCIENTIFIC AB (SE) 2021-03-04 — — US disclosed
US-20170020874-A1 COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS CERENO SCIENT AB (SE) 2017-01-26 — — US disclosed
US-20140051716-A1 COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS CERENO SCIENTIFIC AB 2014-02-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051716-A1 COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS HDAC3, HDAC1, HDAC2 HDAC3 1/4885HDAC1 2/4885HDAC2 3/4885
US-20170020874-A1 COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS HDAC3, HDAC1, HDAC2 HDAC3 1/4885HDAC1 2/4885HDAC2 3/4885
US-20210060014-A1 COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS HDAC3, HDAC1, HDAC2 HDAC3 1/4885HDAC1 2/4885HDAC2 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.